se and adherence of Inhalers in COPD and Asthma patients
Not Applicable
- Conditions
- Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecifiedHealth Condition 2: J459- Other and unspecified asthma
- Registration Number
- CTRI/2024/02/062955
- Lead Sponsor
- Cipla Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of either gender who are 18 years and above and understand English language and willing to participate in this study will be included.Patients diagnosed with asthma and COPD by the treating physician and prescribed inhaler as part of treatment of COPD or Asthma
Exclusion Criteria
Individuals suffering from malignancies AML and systemic autoimmune disease autoimmune diseases like SLE and other immunosuppressive disorders
Individuals with any serious co-morbidity and existing end organ damage dementia and psychotic illness.
Vulnerable patients less than 18 years old pregnant women Patients who do not understand English
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To examine the adherence of the BA-pMDI device compared to other inhaler devices for treatment of asthmatic and COPD patientsTimepoint: 9 months
- Secondary Outcome Measures
Name Time Method Identification of factors affecting adherence to the BA-pMDI devices and comparison to the different inhaler devices.Timepoint: 9 months